Novo Nordisk (NVO) Debt US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt | 26 645 000 000 | 25 784 000 000 | 27 006 000 000 | 102 787 000 000 | 130 958 000 000 | 146 382 000 000 | |||
| Changes by years, y/y, % | +1 465% | -3% | +5% | +281% | +27% | +138.4% | |||
Novo Nordisk. Debt
Novo Nordisk. Debt, changes, %
Novo Nordisk (NVO) Debt US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt | 118 723 000 000 | 99 268 000 000 | 101 214 000 000 | 130 958 000 000 | 146 382 000 000 | 146 382 000 000 | ||
| Changes by years, y/y, % | +341% | +1 111% | +78% | +27% | +23% | |||
| Changes by quarters, q/q, % | +16% | -16% | +2% | +29% | +12% | |||